SANTEN PHARMACEUTICAL CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 79176
 
  
 
C07D HETEROCYCLIC COMPOUNDS 21141
 
  
 
2403 PROSTHETIC ARTICLES132
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 11129
 
  
 
2402 MEDICAL INSTRUMENTS, INSTRUMENTS AND TOOLS FOR LABORATORY USE835
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 7131
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
0907 CLOSING MEANS AND ATTACHMENTS522
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 494
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,313 DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENTApr 01, 16Mar 15, 18[A61K]
2018/0021,314 THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTIONOct 02, 17Jan 25, 18[A61K]
2018/0015,166 POLYAPHRONS AND PALPEBRAL ADMINISTRATION THEREOFFeb 02, 16Jan 18, 18[A61K]
2018/0000,729 DEPOT FORMULATIONSJun 29, 17Jan 04, 18[A61K, C12P, C08G, C07C]
2017/0340,644 OPHTHALMIC AQUEOUS COMPOSITIONNov 05, 15Nov 30, 17[A61K, C08G, C07C, C07J]
2017/0312,174 Eye Drop Container Having Identifying IndiciaOct 20, 15Nov 02, 17[A61J, A61F, B65D]
2017/0304,046 INTRAOCULAR LENS INJECTOROct 22, 15Oct 26, 17[A61F]
2017/0266,109 RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USEJun 01, 17Sep 21, 17[A61K]
2017/0202,845 PROPHYLACTIC OR THERAPEUTIC AGENT FOR A POSTERIOR OCULAR DISEASEJul 17, 15Jul 20, 17[A61K]
2017/0182,085 THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERJul 13, 15Jun 29, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902698 2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereofDec 02, 16Feb 27, 18[A61K, C07D, C07C]
9827139 Intraocular lens injectorOct 28, 13Nov 28, 17[A61F]
D790707 Intraocular lensApr 07, 15Jun 27, 17[2402]
9676703 Production method for 3,3-dimethyl-3,4-dihydro-1H-quinoxalin-2-one derivative and intermediate for said production methodAug 08, 14Jun 13, 17[C07D, C07C]
9669988 Fixed amount discharge containerApr 26, 12Jun 06, 17[B65D, A61M]
9579309 Prophylactic or therapeutic agent for posterior ocular disease containing tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine derivative as effective ingredientFeb 27, 14Feb 28, 17[A61K]
9546140 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereofMay 10, 16Jan 17, 17[A61K, C07D, C07C]
9539138 Method of ophthalmic surgery and kit thereforJan 29, 09Jan 10, 17[A61K, A61F]
9539204 Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockageSep 28, 12Jan 10, 17[A61K]
9486529 Ophthalmic solution comprising diquafosolMar 25, 13Nov 08, 16[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0247,342 PRODUCTION METHOD FOR 3,3-DIMETHYL-3,4-DIHYDRO-1H-QUINOXALIN-2-ONE DERIVATIVE AND INTERMEDIATE FOR SAID PRODUCTION METHODAbandonedMay 12, 17Aug 31, 17[C07D, C07C]
2017/0049,786 MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERSAbandonedSep 01, 16Feb 23, 17[A61K]
2017/0020,809 LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONSAbandonedJun 15, 16Jan 26, 17[A61K]
2016/0303,093 RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USEAbandonedJun 29, 16Oct 20, 16[A61K]
2016/0228,420 POLYETHYLENE GLYCOL-CONTAINING COMPOSITIONAbandonedSep 18, 14Aug 11, 16[A61K]
2016/0022,648 THERAPEUTIC AGENT FOR MEIBOMIAN GLAND DYSFUNCTIONAbandonedMar 12, 14Jan 28, 16[A61K]
2015/0073,005 COMPOSITION FOR HAIR GROWTHAbandonedNov 17, 14Mar 12, 15[A61K, C07C]
2015/0011,518 NON-AQUEOUS LIQUID COMPOSITIONAbandonedJan 30, 13Jan 08, 15[A61K]
2014/0371,459 INDUSTRIAL PROCESS FOR PREPARATION OF 1,2-DIHYDROQUINOLINE DERIVATIVE OR A SALT THEREOF, AND INTERMEDIATE FOR PREPARATION THEREOFAbandonedJan 21, 13Dec 18, 14[C07D]
2014/0228,425 INHIBITOR FOR CORNEAL EPITHELIAL CELL DEATH, INHIBITOR CHARACTERIZED BY COMBINING HYALURONIC ACID AND FLAVIN ADENINE DINUCLEOTIDEAbandonedSep 26, 12Aug 14, 14[A61K]
2014/0221,306 OPHTHALMIC SOLUTION COMPRISING DIQUAFOSOL, METHOD FOR PRODUCING THE SAME, AND METHOD FOR INHIBITING FORMATION OF INSOLUBLE PRECIPITATEAbandonedDec 27, 11Aug 07, 14[A61K]
2014/0088,039 OPHTHALMIC SOLUTION CONTAINING HYALURONIC ACID OR SALT THEREOF AND PROPYLENE GLYCOLAbandonedJun 22, 12Mar 27, 14[A61K]
8664221 Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituentExpiredSep 11, 09Mar 04, 14[A61K, A01N, C07D]
2014/0045,842 METHOD FOR TREATING AN INFLAMMATORY DISEASE BY ADMINISTERING A 1,2,3,4-TETRAHYDROQUINOXALINE COMPOUND CONTAINING A PHENYL GROUP HAVING A SULFONIC ACID ESTER STRUCTURE INTRODUCED THEREIN AS A SUBSTITUENTAbandonedOct 22, 13Feb 13, 14[C07D]
2014/0018,350 COMBINATION OF SULFONAMIDE COMPOUND AND TAFLUPROSTAbandonedJul 11, 13Jan 16, 14[A61K]
8580784 Method for treating a disease related to the glucocorticoid receptorExpiredJul 14, 11Nov 12, 13[A61K]
8569493 Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compoundExpiredFeb 02, 12Oct 29, 13[C07D]
8563551 Method for preventing or treating a disease related to the glucocorticoid receptorExpiredJun 30, 11Oct 22, 13[A61K]
2013/0275,349 Comprehensive Glaucoma Determination Method Utilizing Glaucoma Diagnosis Chip And Deformed Proteomics Cluster AnalysisAbandonedDec 28, 11Oct 17, 13[G06N]
8536207 Method for treating a keratoconjunctival disorderExpiredMay 24, 12Sep 17, 13[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.